Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Management of Pediatric Bronchiolitis

Diagnosis and Characterization

  • Bronchiolitis is a clinical diagnosis in infants less than 2 years of age that does not require diagnostic testing, characterized by first episode of wheezing associated with respiratory symptoms such as rhinitis, tachypnea, and increased respiratory effort 1
  • Risk factors for severe disease include age less than 12 weeks, history of prematurity, underlying cardiopulmonary disease, or immunodeficiency 1

Evidence Against Routine Corticosteroid Use

  • Systematic reviews and meta-analyses involving nearly 1200 children have not shown sufficient evidence to support steroid use in bronchiolitis 3
  • The American Academy of Pediatrics recommends focusing on supportive care and monitoring 1, 2
  • Assess hydration and ability to take fluids orally (strong recommendation) 1
  • Provide supplemental oxygen if SpO2 falls persistently below 90% in previously healthy infants 1
  • Discontinue oxygen when SpO2 is at or above 90% and the infant is feeding well with minimal respiratory distress 1
  • Avoid routine use of other medications including bronchodilators, antibiotics, and chest physiotherapy 1, 2

Prevention

  • Hand decontamination is the most important step in preventing spread of respiratory syncytial virus (RSV) 1
  • Infants should not be exposed to passive smoking (strong recommendation) 2
  • Breastfeeding is recommended to decrease a child's risk of having lower respiratory tract disease 2
  • Palivizumab prophylaxis may be considered for infants with history of prematurity or congenital heart disease 1